One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...

As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...

After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

The former top vaccines official at the Food and Drug Administration criticized Health and Human Services Secretary Robert F.

The FDA missed the April 1 regulatory decision target date for Novavax’s Covid-19 vaccine. Politico reported the holdup was due to the intervention of Sara Brenner, the FDA’s principal deputy ...

The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Directives from President Donald Trump's administration to freeze grant funding from the National Institutes of Health may ...

When asked if the delay resulted from "personnel being shuffled" at the FDA, Kennedy attributed it to the vaccine's composition. Josh Lipton explores some of the top stories on Yahoo Finance's Market ...

Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...